Procter & Gamble Health Limited announced today its financial results for the quarter ended March 31, 2022. The Company has delivered total sales of ₹ 262 crores for the quarter ended March 31, 2022 vs ₹ 214 crores, up by 23% vs year ago.
The Profit After Tax (PAT) was ₹ 51.2 crores, up by 224% vs year ago. Increase in PAT is driven by higher sales and lower marketing and depreciation charge vs same period last year. Sales for the nine-month period ending March 31, 2022, were ₹ 803 crores, vs ₹ 710 crores up 13% vs a year ago. PAT for nine-month period is ₹ 151 crore Vs ₹143 crore a year ago, despite high inflationary pressures.